+ Follow TOCILIZUMAB Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2128924
[Title] => FDA warns public against black market tocilizumab
[Summary] => Health authorities have said the country's supply of the arthritis drug will remain limited until the end of the year.Â
[DatePublished] => 2021-09-22 12:36:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1806910
[AuthorName] => Christian Deiparine
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2021/09/22/chapel-22021-08-2215-50-34_2021-09-22_12-25-26595_thumbnail.jpg
)
[1] => Array
(
[ArticleID] => 2127663
[Title] => Philippines can’t secure enough Tocilizumab – Galvez
[Summary] => The Philippines is encountering difficulties in securing enough supply of Tocilizumab, a drug administered to COVID-19 patients, a Palace official said yesterday.
[DatePublished] => 2021-09-17 00:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1805309
[AuthorName] => Alexis Romero
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2021/09/16/toc_2021-09-16_21-41-41173_thumbnail.jpg
)
[2] => Array
(
[ArticleID] => 2124855
[Title] => DOH warns of imprisonment, fine for tocilizumab price gougers
[Summary] => The Department of Health warned Saturday that sellers of tocilizumab who do not follow its suggested retail price would be jailed and fined, amid a global shortage in the drug used off-label to treat patients hospitalized due to COVID-19
[DatePublished] => 2021-09-04 15:19:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2021/09/02/chapel-icu-4_2021-09-02_18-16-18_thumbnail.jpg
)
[3] => Array
(
[ArticleID] => 937146
[Title] => Right medication helps rheumatoid arthritis patient live normally anew
[Summary] => Jean Vasquez was a hard worker at the University of the East Ramon Magsaysay Medical Center. She was a cashier in the outpatient clinic and was accustomed to meeting different types of patients and seeing many different types of conditions.
[DatePublished] => 2013-05-02 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 786113
[Title] => Arthritis patients can live healthy, normal lives
[Summary] => Anna was always very active. When she was younger, she was heavily into kickboxing, scuba diving, and several other high-impact sports and exercises.
[DatePublished] => 2012-03-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 784577
[Title] => Helping rheumatoid arthritis patients live healthy, normal lives
[Summary] => Anna was always very active.
[DatePublished] => 2012-03-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 691717
[Title] => Roche announces new study data on rheumatoid arthritis treatment
[Summary] => Roche recently announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress.
[DatePublished] => 2011-06-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 682217
[Title] => Roche drug for treating systemic juvenile idiopathic arthritis gets US FDA approval
[Summary] => The United States Food and Drug Administration (FDA) has approved Roche’s drug tocilizumab for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged two and older.
[DatePublished] => 2011-05-05 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
TOCILIZUMAB
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2128924
[Title] => FDA warns public against black market tocilizumab
[Summary] => Health authorities have said the country's supply of the arthritis drug will remain limited until the end of the year.Â
[DatePublished] => 2021-09-22 12:36:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1806910
[AuthorName] => Christian Deiparine
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2021/09/22/chapel-22021-08-2215-50-34_2021-09-22_12-25-26595_thumbnail.jpg
)
[1] => Array
(
[ArticleID] => 2127663
[Title] => Philippines can’t secure enough Tocilizumab – Galvez
[Summary] => The Philippines is encountering difficulties in securing enough supply of Tocilizumab, a drug administered to COVID-19 patients, a Palace official said yesterday.
[DatePublished] => 2021-09-17 00:00:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1805309
[AuthorName] => Alexis Romero
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2021/09/16/toc_2021-09-16_21-41-41173_thumbnail.jpg
)
[2] => Array
(
[ArticleID] => 2124855
[Title] => DOH warns of imprisonment, fine for tocilizumab price gougers
[Summary] => The Department of Health warned Saturday that sellers of tocilizumab who do not follow its suggested retail price would be jailed and fined, amid a global shortage in the drug used off-label to treat patients hospitalized due to COVID-19
[DatePublished] => 2021-09-04 15:19:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] => https://media.philstar.com/photos/2021/09/02/chapel-icu-4_2021-09-02_18-16-18_thumbnail.jpg
)
[3] => Array
(
[ArticleID] => 937146
[Title] => Right medication helps rheumatoid arthritis patient live normally anew
[Summary] => Jean Vasquez was a hard worker at the University of the East Ramon Magsaysay Medical Center. She was a cashier in the outpatient clinic and was accustomed to meeting different types of patients and seeing many different types of conditions.
[DatePublished] => 2013-05-02 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 786113
[Title] => Arthritis patients can live healthy, normal lives
[Summary] => Anna was always very active. When she was younger, she was heavily into kickboxing, scuba diving, and several other high-impact sports and exercises.
[DatePublished] => 2012-03-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 784577
[Title] => Helping rheumatoid arthritis patients live healthy, normal lives
[Summary] => Anna was always very active.
[DatePublished] => 2012-03-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 691717
[Title] => Roche announces new study data on rheumatoid arthritis treatment
[Summary] => Roche recently announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress.
[DatePublished] => 2011-06-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 682217
[Title] => Roche drug for treating systemic juvenile idiopathic arthritis gets US FDA approval
[Summary] => The United States Food and Drug Administration (FDA) has approved Roche’s drug tocilizumab for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged two and older.
[DatePublished] => 2011-05-05 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
September 4, 2021 - 3:19pm